Lihua Sun - JRSIS Health CEO, Director
| JRSS Stock | USD 0.15 0.02 11.76% |
CEO
Ms. Lihua Sun is Chief Executive Officer, Director of the company. She is one of the cofounder of Jiarun Hospital and has many years in the healthcare industry. She was the former General Manager of Ankang Medicine in Hulan district and a Director of Heilongjiang Dahua Medicine Co., Ltd.
| Age | 58 |
| Phone | 86 451 5688 8933 |
| Web | https://www.jhcc.cn |
JRSIS Health Management Efficiency
The company has return on total asset (ROA) of 0.0911 % which means that it generated a profit of $0.0911 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1824 %, meaning that it created $0.1824 on every $100 dollars invested by stockholders. JRSIS Health's management efficiency ratios could be used to measure how well JRSIS Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | CEO Age | ||
| Raymond Stachowiak | American Shared Hospital | 66 | |
| Lucinda CPA | Brookdale Senior Living | 59 | |
| Lucinda Baier | Brookdale Senior Living | 59 | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0911 |
JRSIS Health Care Leadership Team
Elected by the shareholders, the JRSIS Health's board of directors comprises two types of representatives: JRSIS Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of JRSIS. The board's role is to monitor JRSIS Health's management team and ensure that shareholders' interests are well served. JRSIS Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, JRSIS Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lihua Sun, CEO, Director | ||
| Suya Li, Chief Officer | ||
| Zhuowei Zhong, Chairman Pres | ||
| Zhuowen Chen, CFO Director | ||
| Junsheng Zhang, Chairman of the Board and Presidentident |
JRSIS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is JRSIS Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0911 | |||
| Profit Margin | (0.75) % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 3.28 M | |||
| Shares Outstanding | 58.37 M | |||
| Price To Earning | 0.48 X | |||
| Price To Book | 3.80 X | |||
| Price To Sales | 0.09 X | |||
| Revenue | 44.39 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for JRSIS Pink Sheet Analysis
When running JRSIS Health's price analysis, check to measure JRSIS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JRSIS Health is operating at the current time. Most of JRSIS Health's value examination focuses on studying past and present price action to predict the probability of JRSIS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move JRSIS Health's price. Additionally, you may evaluate how the addition of JRSIS Health to your portfolios can decrease your overall portfolio volatility.